The ‘Public Option’ on Health Care Is a Poison Pill

David U. Himmelstein and Steffie Woolhandler from The Nation, take an in-depth look at how private insurances operate, citing that "the case for a public option rests on faulty economic logic and naive assumptions about how private insurance actually works."  

The  authors explain the three different public options-- buy in, pay-or-play, Medicare Advantage for All--
and why they are not as viable as a single payer system like Medicare for All. 

The ‘Public Option’ on Health Care Is a Poison Pill    David U. Himmelstein and Steffie Woolhandler,  The Nation,

Be the first to comment

Please check your e-mail for a link to activate your account.